China SXT Company Insiders

China SXT Management Team Effectiveness

The company has return on total asset (ROA) of (0.0497) % which means that it has lost $0.0497 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2165) %, meaning that it created substantial loss on money invested by shareholders. China SXT's management efficiency ratios could be used to measure how well China SXT manages its routine affairs as well as how well it operates its assets and liabilities. As of March 25, 2025, Return On Tangible Assets is expected to decline to -0.15. The current year's Return On Capital Employed is expected to grow to -0.19. At present, China SXT's Intangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 11.4 M, whereas Total Assets are forecasted to decline to about 21.9 M. The current year's Common Stock Shares Outstanding is expected to grow to about 1 M, whereas Net Loss is projected to grow to (4.9 M).

China SXT Workforce Comparison

China SXT Profit Margins

The company has Profit Margin (PM) of (1.61) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 7.34 %, which suggests for every 100 dollars of sales, it generated a net operating income of $7.34.

China SXT Pharmaceuticals Benchmark Summation

China SXT Notable Stakeholders

The success or failure of an entity such as China SXT Pharmaceuticals often depends on how effective the management is. China SXT management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of China management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the China management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of China SXT's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, China SXT's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of China SXT's management manipulating its earnings.

When running China SXT's price analysis, check to measure China SXT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China SXT is operating at the current time. Most of China SXT's value examination focuses on studying past and present price action to predict the probability of China SXT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China SXT's price. Additionally, you may evaluate how the addition of China SXT to your portfolios can decrease your overall portfolio volatility.